Aprea Therapeutics, Inc.
APRE
$1.64
$0.042.50%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.24M | -3.93M | -2.89M | -3.78M | -3.47M |
| Total Depreciation and Amortization | 5.40K | 5.40K | 5.40K | 5.40K | 5.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 165.90K | 170.40K | 86.80K | 184.60K | 134.00K |
| Change in Net Operating Assets | -63.20K | 125.60K | -708.40K | 1.13M | -310.90K |
| Cash from Operations | -3.13M | -3.63M | -3.51M | -2.47M | -3.64M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | -7.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | 0.00 | -7.50K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 399.80K | 59.20K | 140.80K | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -14.90K | -3.40K | -6.40K | -1.20K | -21.10K |
| Cash from Financing | 384.90K | 55.80K | 134.40K | -1.20K | -21.10K |
| Foreign Exchange rate Adjustments | 2.60K | 1.40K | -24.60K | 24.70K | -4.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.74M | -3.57M | -3.40M | -2.44M | -3.68M |